Trial_ID
stringclasses 7
values | Patient_ID
stringlengths 4
4
| Drug_A_Dosage_mg
int64 100
220
| Drug_B_Dosage_mg
int64 40
100
| Age_Years
int64 35
77
| BMI
float64 21.5
35.2
| Baseline_Condition_Score
float64 4
9.9
| Response_Category
stringclasses 4
values | Adverse_Events_Count
int64 0
4
| Primary_Endpoint_Value
float64 0.01
0.98
| Time_to_Relapse_Days
int64 15
600
|
|---|---|---|---|---|---|---|---|---|---|---|
TRIAL001
|
P001
| 150
| 50
| 62
| 28.5
| 7.8
|
Complete Response
| 1
| 0.92
| 450
|
TRIAL001
|
P002
| 150
| 50
| 45
| 24.1
| 6.5
|
Partial Response
| 0
| 0.45
| 180
|
TRIAL001
|
P003
| 150
| 50
| 71
| 32.9
| 9.1
|
Stable Disease
| 3
| 0.15
| 90
|
TRIAL001
|
P004
| 150
| 50
| 55
| 26.7
| 5.9
|
Complete Response
| 0
| 0.88
| 510
|
TRIAL001
|
P005
| 150
| 50
| 38
| 22.3
| 4.2
|
No Response
| 0
| 0.05
| 30
|
TRIAL002
|
P006
| 200
| 75
| 58
| 30.1
| 8.5
|
Partial Response
| 2
| 0.61
| 240
|
TRIAL002
|
P007
| 200
| 75
| 67
| 27.8
| 7.3
|
Complete Response
| 1
| 0.95
| 600
|
TRIAL002
|
P008
| 200
| 75
| 51
| 25.5
| 5.1
|
Stable Disease
| 0
| 0.33
| 120
|
TRIAL002
|
P009
| 200
| 75
| 74
| 35.2
| 9.8
|
No Response
| 4
| 0.01
| 15
|
TRIAL002
|
P010
| 200
| 75
| 41
| 23.9
| 6
|
Partial Response
| 0
| 0.55
| 210
|
TRIAL003
|
P011
| 100
| 100
| 60
| 29.3
| 8
|
Complete Response
| 0
| 0.98
| 550
|
TRIAL003
|
P012
| 100
| 100
| 49
| 25
| 7
|
Partial Response
| 1
| 0.52
| 160
|
TRIAL003
|
P013
| 100
| 100
| 77
| 31.5
| 9.5
|
Stable Disease
| 2
| 0.2
| 80
|
TRIAL003
|
P014
| 100
| 100
| 53
| 24.8
| 5.5
|
Complete Response
| 0
| 0.85
| 480
|
TRIAL003
|
P015
| 100
| 100
| 44
| 26
| 6.2
|
No Response
| 0
| 0.1
| 45
|
TRIAL004
|
P016
| 175
| 60
| 65
| 33
| 8.9
|
Partial Response
| 3
| 0.7
| 280
|
TRIAL004
|
P017
| 175
| 60
| 40
| 21.5
| 4
|
Complete Response
| 0
| 0.9
| 530
|
TRIAL004
|
P018
| 175
| 60
| 70
| 29.9
| 7.5
|
Stable Disease
| 1
| 0.3
| 100
|
TRIAL004
|
P019
| 175
| 60
| 57
| 27
| 6.8
|
No Response
| 0
| 0.12
| 50
|
TRIAL004
|
P020
| 175
| 60
| 48
| 25.5
| 5.2
|
Partial Response
| 1
| 0.65
| 220
|
TRIAL005
|
P021
| 120
| 80
| 63
| 28
| 7.9
|
Complete Response
| 1
| 0.94
| 470
|
TRIAL005
|
P022
| 120
| 80
| 42
| 23.5
| 6.1
|
Partial Response
| 0
| 0.48
| 190
|
TRIAL005
|
P023
| 120
| 80
| 75
| 34
| 9.9
|
Stable Disease
| 2
| 0.18
| 70
|
TRIAL005
|
P024
| 120
| 80
| 50
| 26.2
| 5.8
|
Complete Response
| 0
| 0.82
| 490
|
TRIAL005
|
P025
| 120
| 80
| 35
| 21.9
| 4.5
|
No Response
| 0
| 0.08
| 35
|
TRIAL006
|
P026
| 220
| 40
| 68
| 30.5
| 8.8
|
Partial Response
| 3
| 0.58
| 250
|
TRIAL006
|
P027
| 220
| 40
| 47
| 24.4
| 5
|
Complete Response
| 0
| 0.87
| 500
|
TRIAL006
|
P028
| 220
| 40
| 72
| 32
| 9.3
|
Stable Disease
| 1
| 0.25
| 95
|
TRIAL006
|
P029
| 220
| 40
| 54
| 26.9
| 6.4
|
No Response
| 2
| 0.03
| 20
|
TRIAL006
|
P030
| 220
| 40
| 39
| 22.8
| 4.1
|
Partial Response
| 0
| 0.4
| 150
|
TRIAL007
|
P031
| 160
| 70
| 61
| 27.5
| 7.7
|
Complete Response
| 1
| 0.91
| 460
|
TRIAL007
|
P032
| 160
| 70
| 46
| 24
| 6.6
|
Partial Response
| 0
| 0.46
| 170
|
No dataset card yet
- Downloads last month
- 5